Paper · 52685
Bifunctional major histocompatibility-linked genetic regulation of cell-mediated lympholysis to trinitrophenyl-modified autologous lymphocytes.
Schmitt-Verhulst AM and 1 other. J Exp Med, 1975. Cited by 76 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Bifunctional major histocompatibility-linked genetic regulation of cell-mediated lympholysis to trinitrophenyl-modified autologous lymphocytes. Papers, record 52685. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/52685
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bifunctional major histocompatibility-linked genetic regulation of cell-mediated lympholysis to trinitrophenyl-modified autologous lymphocytes.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genes | Major topic |
| Histocompatibility | Major topic |
| Immunity, Cellular | Major topic |
| T-Lymphocytes | Major topic |
| Alleles | |
| Animals | |
| Autoantigens | |
| Cytotoxicity Tests, Immunologic | |
| Epitopes | |
| Genes, Regulator | |
| Genetic Linkage | |
| Lymphocyte Culture Test, Mixed | |
| Male | |
| Mice | |
| Nitrophenols | |
| Spleen | |
| Trinitrobenzenesulfonic Acid |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,079,922 | Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus. | Nature | 1975 | https://conductscience.org/library/papers/1079922 | PubMed |
| 2 | 1,086,219 | Cell-medicated cytotoxicity against ectromelia virus-infected target cells. III. Role of the H-2 gene complex. | Eur J Immunol | 1975 | https://conductscience.org/library/papers/1086219 | PubMed |
| 3 | 123,002 | H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. | J Exp Med | 1975 | https://conductscience.org/library/papers/123002 | PubMed |
| 4 | 4,108,876 | The H-2 model for the major histocompatibility systems. | Transplant Rev | 1971 | https://conductscience.org/library/papers/4108876 | PubMed |
| 5 | 4,128,439 | A mouse B-cell alloantigen determined by gene(s) linked to the major histocompatibility complex. | J Exp Med | 1973 | https://conductscience.org/library/papers/4128439 | PubMed |
| 6 | 4,133,807 | Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. | Nature | 1974 | https://conductscience.org/library/papers/4133807 | PubMed |
| 7 | 4,134,154 | HL-A, immune-response genes, and disease. | Lancet | 1974 | https://conductscience.org/library/papers/4134154 | PubMed |
| 8 | 4,136,175 | Antigen-specific thymus cell factors in the genetic control of the immune response to poly-(tyrosyl, glutamyl)-poly-D, L-alanyl--poly-lysyl. | J Exp Med | 1974 | https://conductscience.org/library/papers/4136175 | PubMed |
| 9 | 4,204,563 | Autoimmune murine thyroiditis. IV. Localization of genetic control of the immune response. | J Immunol | 1974 | https://conductscience.org/library/papers/4204563 | PubMed |
| 10 | 4,215,740 | The genetic control of T cell-meditated immunity. I. Characterization of a mouse strain whose low responsiveness is inherited as a recessive trait. | Immunology | 1974 | https://conductscience.org/library/papers/4215740 | PubMed |
1 to 10 of 20
See all 20 referencesCited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30,687,803 | Peter Doherty, Nobel Laureate: Questions and Reflections Concerning MHC Restriction and other Fruits of a Life of Biomedical Erudition. | Pathog Immun | 2018 | https://conductscience.org/library/papers/30687803 | PubMed |
| 7,025,308 | HLA restriction of human cytotoxic T cells. | Springer Semin Immunopathol | 1980 | https://conductscience.org/library/papers/7025308 | PubMed |
| 6,972,996 | Major histocompatibility complex restriction of soluble helper molecules in T cell responses to altered self. | J Exp Med | 1981 | https://conductscience.org/library/papers/6972996 | PubMed |
| 6,932,473 | Selective turnover and shedding of H-2K and H-2D antigens is controlled by the major histocompatibility complex. Implications for H-2-restricted recognition. | J Exp Med | 1980 | https://conductscience.org/library/papers/6932473 | PubMed |
| 6,610,062 | Virus specificity of cytotoxic T lymphocytes generated during acute lymphocytic choriomeningitis virus infection: role of the H-2 region in determining cross-reactivity for different lymphocytic choriomeningitis virus strains. | J Virol | 1984 | https://conductscience.org/library/papers/6610062 | PubMed |
| 6,600,441 | Recognition and lysis of altered-self cells by macrophages. I. Modification of target cells by 2,4,6-trinitrobenzene sulphonic acid. | Immunology | 1983 | https://conductscience.org/library/papers/6600441 | PubMed |
| 6,444,234 | Role of self carriers in the immune response and tolerance. V. Reversal of trinitrophenyl-modified self suppression of the B-cell response by blocking of H-2 antigens. | J Exp Med | 1980 | https://conductscience.org/library/papers/6444234 | PubMed |
| 6,425,221 | Role of the H-2s haplotype in survival of mice after infection with Trypanosoma cruzi. | Infect Immun | 1984 | https://conductscience.org/library/papers/6425221 | PubMed |
| 6,219,064 | Mouse immunoglobulin isotypes mediating cytotoxicity of target cells by eosinophils and neutrophils. | Immunology | 1983 | https://conductscience.org/library/papers/6219064 | PubMed |
| 6,201,586 | Trinitrophenyl modification of H-2k and H-2b spleen cells results in enhanced serological detection of Kk-like determinants. | J Exp Med | 1984 | https://conductscience.org/library/papers/6201586 | PubMed |
1 to 10 of 31
See all 31 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/52685
GET https://conductscience.org/api/papers/v1/52685/cited_by?page=2